Outcome of Board Meeting held on May 21, 2026

Pat Growth 25pctExceptional ItemRelated Party TransactionsResults View source PDF

MAXHEALTH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-8.5%1-day move

₹1093.15

prior close

₹1068.25

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-2.7-3.9-4.7-4.6-8.5-9.2-9.0-11.7-13.7-11.7-5.8-0.0-1.1—

Up moveDown movePending

AI summary

Max Healthcare approved audited Q4 and FY26 results with strong performance. Consolidated revenue grew 19% to ₹8,37,345 lakhs while consolidated PAT jumped 34% to ₹1,44,241 lakhs versus prior year. Standalone PAT stood at ₹71,661 lakhs. EPS (consolidated annual) improved to ₹14.83 from ₹11.07. Auditors S.R. Batliboi & Co. LLP issued an unmodified (clean) opinion. Exceptional items of ₹4,824 lakhs include ₹3,390 lakhs impact of new Labour Codes and ₹1,434 lakhs stamp duty provision. A tax benefit of ₹14,148 lakhs from the CRL-JHL merger was recognized. Board recommended dividend of ₹2 per share. Other approvals include construction of a ~712-bed hospital in Lucknow, acquisition of Kalinga Hospitals (58.28% stake for ₹29,797 lakhs), and reclassification of Radiant Life Care Hospital Foundation from promoter to public category.

Likely market impact

Strong earnings growth with 34% PAT increase is positive for shareholders. The clean audit opinion removes any concern about financial reporting quality. New hospital construction and acquisition signal expansion but involve significant capital deployment.